• 1
    Sharp GC, Irvin WS, Tan EM, Gould RG, Holman RH. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 14859.
  • 2
    Alpert MA, Goldberg SH, Singsen BH, Durham JB, Sharp GC, Ahmad M, et al. Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation 1983; 68: 118293.
  • 3
    Oetgen WJ, Mutter ML, Lawless OJ, Davia JE. Cardiac abnormalities in mixed connective tissue disease. Chest 1983; 83: 1858.
  • 4
    Langley RL, Treadwell EL. Cardiac tamponade and pericardial disorders in connective tissue diseases: case report and literature review. J Natl Med Assoc 1994; 86: 14953.
  • 5
    Singsen BH, Bernstein BH, Kornreich HK, King KK, Hanson V, Tan EM. Mixed connective tissue disease in childhood: a clinical and serologic survey. J Pediatr 1977; 90: 893900.
  • 6
    Kasukawa R. Mixed connective tissue disease. Intern Med 1999; 38: 38693.
  • 7
    Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, et al, and The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary. Eur Heart J 2004; 25: 587610.
  • 8
    Zashin SJ, Lipsky PE. Pericardial tamponade complicating systemic lupus erythematosus. J Rheumatol 1989; 16: 3747.
  • 9
    Richard P, Sabouret P, Vayre F, Desrame J, Ollivier JP. Pleuropericarditis complicated of tamponade disclosing mixed connective tissue disease: remission with non-steroidal anti-inflammatory agents: apropos of a case. Ann Cardiol Angeiol (Paris) 1996; 45: 5135.
  • 10
    Inoue T, Kamishirado H, Ishiyama E, Hayashi T, Morooka S. Fulminant hepatic failure due to cardiac tamponade associated with mixed connective tissue disease. J Med 1997; 28: 12935.
  • 11
    Bezerra MC, Saraiva F Jr, Carvalho JF, Caleiro MT, Goncalves CR, Borba EF. Cardiac tamponade due to massive pericardial effusion in mixed connective tissue disease: reversal with steroid therapy. Lupus 2004; 13: 61820.
  • 12
    Porcel JM, Selva A, Tornos MP, Galve E, Soler-Soler J. Resolution of cardiac tamponade in systemic lupus erythematosus with indomethacin. Chest 1989; 96: 11934.
  • 13
    Adler Y, Finkelstein Y, Guindo J, Rodriguez de la Serna A, Shoenfeld Y, Bayes- Genis A, et al. Colchicine treatment for recurrent pericarditis: a decade of experience. Circulation 1998; 97: 21835.
  • 14
    Kahl LE. The spectrum of pericardial tamponade in systemic lupus erythematosus: report of ten patients. Arthritis Rheum 1992; 35: 13439.
  • 15
    Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation 2005; 112: 20126.
  • 16
    Seve P, Stankovic K, Broussolle C. Effectiveness of colchicine in a case of recurrent compressive rheumatoid pericarditis. Rheumatol Int 2005; 25: 55861.
  • 17
    Fernandez-Muixi J, Vidal F, Bardaji A, Richart C. Recurrent pericarditis and cardiac tamponade in rheumatoid arthritis: effectiveness of colchicine [letter]. Br J Rheumatol 1994; 33: 5967.
  • 18
    Marcolongo R, Russo R, Laveder F, Noventa F, Agostini C. Immunosuppressive therapy prevents recurrent pericarditis. J Am Coll Cardiol 1995; 26: 12769.